UNSPSC 51372803: Nefopam

This classification denotes a benzodiazepine with the molecular formula C17H19NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4UP8060B7J, chemically known as 3,4,5,6-tetrahydro-5-methyl-1-phenyl-1h-2,5-benzoxazocin but generally known as nefopam, which bears US NIH Compound Identifier 4450. European Medicines Agency schedules Nefopam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09183MIG.

UNSPSC 51372803 Nefopam, a Commodity code, does not align with the state and local solicitations currently tagged under it. The code nominally refers to a specific pharmaceutical active ingredient, but recent opportunities posted under this code involve naloxone distribution, direct-to-manufacturer pharmacy programs, and generic multi-source pharmaceutical procurement — none of which directly concern nefopam supply or formulation.

The mismatch reflects a common classification issue in state and local procurement databases where pharmaceutical codes are applied broadly across different drug-procurement initiatives rather than by active ingredient. Seminole County, Florida (IFB 60459723LAS, due July 26, 2023) solicited naloxone and drug deactivation systems through competitive bid; the Texas Health and Human Services Commission (RFI HHS0017013, April 2026) sought vendor capabilities for a direct-to-manufacturer prescription program; and the Minnesota Multistate Cooperative Purchasing Alliance (RFP S1070000015802, due March 26, 2026) established contracts for generic multi-source pharmaceuticals and OTC products through three authorized wholesalers. Activity spans state health departments, county health services, and cooperative purchasing vehicles serving multiple jurisdictions across Florida, Texas, and Minnesota. Given the code's specificity to nefopam and the absence of nefopam-related opportunities in recent postings, this code shows little relevant recent procurement activity in state and local markets.